Streetbeat News

Price Targets

PVH

Wells Fargo has reaffirmed its Overweight rating on PVH Corp (NYSE:PVH) and increased its price target from $110.00 to $140.00. PVH's shares have risen 1.01% in the last 24 hours to $109.35. The new price target suggests a potential upside of 28.03%. PVH, known for its Calvin Klein and Tommy Hilfiger brands, operates in over 40 countries with a focus on various fashion segments and has a history dating back to 1881.

Portfolio Pulse from Benzinga Insights

December 11, 2023 | 5:00 pm

ATNM

B. Riley Securities analyst Yuan Zhi has maintained a Buy rating on Actinium Pharma (AMEX:ATNM) but reduced the price target from $20 to $16.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 4:52 pm

GIS

Evercore ISI Group analyst David Palmer has maintained an In-Line rating on General Mills (NYSE:GIS) but has lowered the price target from $75 to $72.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 4:50 pm

FLNC

RBC Capital analyst Shelby Tucker has maintained an Outperform rating on Fluence Energy (NASDAQ:FLNC) and increased the price target from $32 to $33.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 4:48 pm

RRC

Citigroup analyst Paul Diamond has maintained a Neutral rating on Range Resources (NYSE:RRC) and reduced the price target from $36 to $33.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 4:47 pm

WSO

Stephens & Co. analyst Tommy Moll has maintained an Overweight rating on Watsco (NYSE:WSO) and increased the price target from $450 to $500.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 4:46 pm

CHK

Citigroup analyst Paul Diamond has maintained a Neutral rating on Chesapeake Energy (NASDAQ:CHK) but has reduced the price target from $90 to $82.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 4:45 pm

LYB

RBC Capital analyst Arun Viswanathan maintains an Outperform rating on LyondellBasell Industries (NYSE:LYB) but reduces the price target from $116 to $108.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 4:41 pm

CRSP

RBC Capital analyst Luca Issi has maintained a 'Sector Perform' rating on CRISPR Therapeutics (NASDAQ:CRSP) and increased the price target from $50 to $57.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 4:41 pm

TLS

Northland Capital Markets analyst Nehal Chokshi has maintained an Outperform rating on Telos Corporation (NASDAQ:TLS) and increased the price target from $4 to $6.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 4:38 pm